Connections in CIDP: From Clinical Need to Future Care
Exploring clinical gaps and what’s next in CIDP managementThis medical symposium explores the evolving clinical landscape of chronic inflammatory demyelinating polyneuropathy (CIDP), with a focus on unmet needs, including residual disability and axonal injury, and their impact on long-term patient outcomes. This 1-hour program examines challenges in identifying and effectively managing CIDP, while highlighting emerging tools that may help inform more individualized care.
Note from the Speakers
Symposium Highlights
Library of Congress
This Symposium is intended for medical and scientific exchange purposes with health care professionals and patient advocacy group leadership only. This program is non-promotional, is sponsored by Sanofi Medical, and the content contained in this presentation was developed by Sanofi Medical in collaboration with the speakers. The speakers were compensated by Sanofi in connection with this presentation. This presentation is not eligible for CME. This Symposium discusses treatment agents that are investigational and no conclusions regarding safety and efficacy should be drawn. For approved agents referenced in this Symposium, please refer to the prescribing information available in your country.